PI
ELV icon

PEAK6 Investments’s Elevance Health ELV Stock Holding History

PEAK6 Investments’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$8.01M Buy
15,400
+7,000
+83% +$3.74M 0.02% 678
2024
Q2 		$4.55M Buy
8,400
+3,900
+87% +$2.06M 0.01% 902
2024
Q1 		$2.33M Sell
4,500
-300
-6% -$149K 0.01% 1306
2023
Q4 		$2.26M Buy
4,800
+500
+12% +$231K 0.01% 1418
2023
Q3 		$1.87M Sell
4,300
-300
-7% -$136K 0.01% 1376
2023
Q2 		$2.04M Buy
4,600
+3,100
+207% +$1.43M 0.01% 1179
2023
Q1 		$690K Sell
1,500
-7,500
-83% -$3.57M ﹤0.01% 2132
2022
Q4 		$4.62M Buy
9,000
+6,800
+309% +$3.45M 0.03% 767
2022
Q3 		$999K Sell
2,200
-2,600
-54% -$1.24M ﹤0.01% 2209
2022
Q2 		$2.14M Sell
4,800
-7,100
-60% -$3.51M ﹤0.01% 2255
2022
Q1 		$5.85M Sell
11,900
-700
-6% -$320K 0.01% 1004
2021
Q4 		$5.84M Buy
12,600
+100
+0.8% +$42.1K 0.01% 1040
2021
Q3 		$4.66M Sell
12,500
-23,728
-65% -$9.02M 0.01% 1206
2021
Q2 		$14.9M Buy
36,228
+20,428
+129% +$7.81M 0.04% 494
2021
Q1 		$5.67M Sell
15,800
-9,200
-37% -$2.96M 0.01% 956
2020
Q4 		$8.03M Sell
25,000
-9,100
-27% -$2.79M 0.02% 789
2020
Q3 		$9.16M Buy
34,100
+28,500
+509% +$7.67M 0.02% 634
2020
Q2 		$1.47M Sell
5,600
-6,400
-53% -$1.71M 0.01% 1743
2020
Q1 		$2.72M Buy
12,000
+11,400
+1,900% +$3.11M 0.02% 839
2019
Q4 		$181K Sell
600
-100
-14% -$27.5K ﹤0.01% 2610
2019
Q3 		$168K Sell
700
-19,800
-97% -$5.43M ﹤0.01% 3002
2019
Q2 		$5.79M Buy
20,500
+200
+1% +$54.6K 0.04% 611
2019
Q1 		$5.83M Sell
20,300
-100
-0.5% -$28.9K 0.03% 627
2018
Q4 		$5.36M Buy
20,400
+8,000
+65% +$2.2M 0.03% 595
2018
Q3 		$3.4M Buy
+12,400
New +$3.22M 0.01% 1035

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PEAK6 Investments's ELV Position: Q3 2024 in Review

PEAK6 Investments sold out of Elevance Health (ELV) in Q3 2024, closing a stake of 2 shares — an estimated $1.07K sold.

PEAK6 Investments first reported a position in ELV in Q1 2019 and held it in 20 quarters. The position peaked at $17.4M in Q2 2019. 1,693 funds tracked by Wall St. Rank hold ELV as of Q3 2024.

  • PEAK6 Investments reported no remaining Elevance Health position as of Q3 2024 after selling out during the quarter.
  • PEAK6 Investments sold 2 Elevance Health shares in Q3 2024, an estimated $1.07K.
  • PEAK6 Investments first reported a position in Elevance Health in Q1 2019 and held it in 20 quarters.
  • PEAK6 Investments's Elevance Health position peaked at $17.4M in Q2 2019.
  • 1,693 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.